Bharat Biotech gets regulator nod for Phase-3 trial of nasal vaccine

Hyderabad-based drug maker Bharat Biotech has got regulatory approval to start Phase-3 clinical trials to test its intranasal Covid vaccine as booster dose (third dose) on people who have received both doses of Covaxin, an official source said.